Assured Investment Management’s Teva Pharmaceuticals TEVA Stock Holding History

Assured Investment Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-3,248,913	Closed	-$30M	–	34
2019 Q2	$30M	Buy	3,248,913 +538,890	+20%	+$6.5M	7.62%	4
2019 Q1	$42.5M	Sell	2,710,023 -173,025	-6%	-$3.05M	0.47%	7
2018 Q4	$44.5M	Buy	2,883,048 +902,162	+46%	+$18.5M	1.26%	4
2018 Q3	$42.7M	Buy	1,980,886 +882,170	+80%	+$20.5M	0.77%	18
2018 Q2	$26.7M	Sell	1,098,716 -901,284	-45%	-$18.4M	0.5%	32
2018 Q1	$34.2M	Hold	2,000,000	–	–	0.78%	15
2017 Q4	$37.9M	Buy	+2,000,000	New	+$30.1M	0.76%	16
2016 Q1	–	Sell	-1,522,545	Closed	-$99.9M	–	722
2015 Q4	$99.9M	Buy	+1,522,545	New	+$94.1M	1.75%	11

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return

Assured Investment Management's TEVA Position: Q3 2019 in Review

Assured Investment Management sold out of Teva Pharmaceuticals (TEVA) in Q3 2019, closing a stake of 3,248,913 shares — an estimated $30M sold.

Assured Investment Management first reported a position in TEVA in Q4 2015 and held it in 8 quarters. The position peaked at $99.9M in Q4 2015. 427 funds tracked by Wall St. Rank hold TEVA as of Q3 2019.

Assured Investment Management reported no remaining Teva Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
Assured Investment Management sold 3,248,913 Teva Pharmaceuticals shares in Q3 2019, an estimated $30M.
Assured Investment Management first reported a position in Teva Pharmaceuticals in Q4 2015 and held it in 8 quarters.
Assured Investment Management's Teva Pharmaceuticals position peaked at $99.9M in Q4 2015.
427 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2019.

Based on Assured Investment Management's 13F filing for Q3 2019, filed 14 Nov 2019.